Ethical issues in gastroenterology research

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue S1, 2015, Pages 8-11

  Eastwood, Gregory L ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Bioethics; Conflicts of interest; Ethics; Human subjects; Research ethics

Indexed keywords

CONFIDENTIALITY; CONFLICT OF INTEREST; GASTROENTEROLOGY; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL RESEARCH; PRIORITY JOURNAL; RESEARCH SUBJECT; REVIEW; SCIENTIFIC MISCONDUCT; ETHICS; RESEARCH ETHICS;

CODES OF ETHICS; CONFLICT OF INTEREST; ETHICS, RESEARCH; GASTROENTEROLOGY; HUMANS; INFORMED CONSENT; RESEARCH SUBJECTS; SCIENTIFIC MISCONDUCT;

EID: 84925966343     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12755     Document Type: Review

References (16)

1. Kitagawa JM. 1. Japan through the nineteenth century. In: Warren T. Reich, ed. Encyclopedia of Bioethics. London: Macmillan Publishing Company, 1995; 1491-1496.
2. Kimura R, Bishop L. Contemporary Japan. In: Warren T. Reich, ed. Encyclopedia of Bioethics. London: Macmillan Publishing Company, 1995; 1496-1505.
3. Tsai DF-C. The bioethical principles and Confucius' moral philosophy. J. Med. Ethics 2005; 31: 159-163.
4. Rice TW. The historical, ethical, and legal background of human-subjects research. Respir. Care 2008; 53: 1325-1329.
5. Reicher H. Medicine in the Third Reich: the 65th anniversary of the doctors' trial at Nuremberg. Penn Med 2012; 23: 28-37.
6. The Nuremberg Code. Directives for Human Experimentation. Available from URL: http://www.hhs.gov/ohrp/archive/nurcode.html (Accessed: October 16, 2014)
7. Wilson EO. Consilience: The Unity of Knowledge. New York: Alfred A. Knopf, Inc., 1998.
8. Brennan TA, Rothman DJ, Blank L etal. Health industry practices that create conflicts of interest. A policy proposal for academic medical centers. JAMA 2006; 295: 429-433.
9. Katz D, Caplan AL, Merz JF. All gifts large and small. Toward an understanding of the ethics of pharmaceutical industry gift-giving. Am. J. Bioeth. 2003; 3: 39-46.
10. Angell M. Industry-sponsored clinical research. A broken system. JAMA 2008; 300: 1069-1071.
11. Policy on Relations with the Pharmaceutical, Medical Device, and Biotechnology Industries. SUNY Upstate Medical University. 2010. Available from URL: http://www.upstate.edu/policies/documents/CAMP_A-24.pdf (Accessed: October 16, 2014)
12. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghost-writing in publications related to rofecoxib. A case study of industry documents from rofecoxib litigation. JAMA 2008; 299: 1800-1812.
13. Lisse JR, Perlman M, Johansson G etal. Gastrointestinal tolerability and effectiveness of rofecoxib vs naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann. Intern. Med. 2003; 139: 539-546.
14. Berenson A. Evidence in Vioxx suits shows intervention by Merck officials. New York Times April 24, 2005:A1.
15. Nylenna M, Andersen D, Dahlquist G, Sarvas M, Aakvaag A. Handling of scientific dishonesty in the Nordic countries. Lancet 1999; 354: 57-61.
16. Martinson BC, Anderson MS, de Vries R. Scientists behaving badly. Nature 2005; 435: 737-738.